Phoenix hospital includes $2M cyclotron in molecular imaging lab
Banner Good Samaritan Medical Center is building a radiopharmaceutical production facility that includes a new $1.8 million cyclotron to expand its clinical and research imaging capabilities in cancer, heart disease and neurology.
The new Banner Good Samaritan Molecular Imaging Laboratory will support all of Banner’s Arizona-based hospitals, other in-patient facilities in the state and outpatient referrals from Arizona, Nevada, New Mexico, Colorado and elsewhere, according to the Phoenix-based healthcare provider.
The researchers at the Banner Alzheimer’s Institute use PET scans to measure brain activity in people with a genetic predisposition to Alzheimer’s disease. The Institute recently started to incorporate two new PET tracers that measure amyloid plaques in the brain, a hallmark of Alzheimer’s disease, into multiple research projects.
“The new cyclotron and Molecular Imaging Laboratory will play a critical role in helping Banner fulfill its patient care and research missions,” according to Eric M. Reiman, MD, executive director of the Banner Alzheimer’s Institute.
The new Banner Good Samaritan Molecular Imaging Laboratory will support all of Banner’s Arizona-based hospitals, other in-patient facilities in the state and outpatient referrals from Arizona, Nevada, New Mexico, Colorado and elsewhere, according to the Phoenix-based healthcare provider.
The researchers at the Banner Alzheimer’s Institute use PET scans to measure brain activity in people with a genetic predisposition to Alzheimer’s disease. The Institute recently started to incorporate two new PET tracers that measure amyloid plaques in the brain, a hallmark of Alzheimer’s disease, into multiple research projects.
“The new cyclotron and Molecular Imaging Laboratory will play a critical role in helping Banner fulfill its patient care and research missions,” according to Eric M. Reiman, MD, executive director of the Banner Alzheimer’s Institute.